Ram leads non-viral delivery platform development at Life Edit Therapeutics. He has more than ten years of experience in non-viral gene delivery, focusing on developing innovative nonviral delivery platforms for nucleic acid therapeutics.

Before joining Life Edit, Ram led non-viral gene delivery as a Principal Scientist at GenEdit. Previously, Ram led lipid nanoparticle platform development at ReCode Therapeutics. Before this, Ram held research positions at Stanford University and Texas A&M University. 

Ram completed a PhD in Organic Synthesis from National Chung Cheng University, Taiwan, as well as a M.S. in Organic Chemistry and a B.S. in Chemistry from Kakatiya University, India.